Compare Abeona Therapeutics Inc (ABEO) vs Waste Management, Inc. (WM) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Waste Management, Inc. — how do they compare? Abeona Therapeutics Inc trades at $6.76 (market cap $373.32M), while Waste Management, Inc. trades at $235.71 (market cap $95.26B). The key difference: Waste Management, Inc. is far larger — about 255.2× Abeona Therapeutics Inc's market cap, and Waste Management, Inc. pays a 1.49% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | WM | |
|---|---|---|
Market Cap | $373.32M | $95.26B |
Sector | Health | Industrials |
52-Week High | $7.23 | $246.51 |
52-Week Low | $4.17 | $196.77 |
Enterprise Value | $228.22M | $117.99B |
Dividend Yield | — | 1.49% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
WM trades at $237.21, up 2.96% today and near its 52-week high of $248.13. The stock shows bullish technical signals with strong moving averages and positive momentum indicators. Fundamentally, revenue grew to $25.20B in 2025 with a net income margin of 10.99%, though recent quarters saw mixed earnings results. Analyst consensus is bullish with a $261 price target, and the company maintains a solid dividend with recent payout of $0.95 per share.
Outlook remains positive driven by pricing discipline and renewable energy initiatives, but risks include elevated valuation multiples and debt levels. The stock offers stability through economic cycles but faces execution risks in maintaining margin growth amid competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Waste Management, Inc.
Waste Management ranks as the largest integrated provider of traditional solid waste services in the United States, operating approximately 260 active landfills and about 340 transfer stations. The company serves residential, commercial, and industrial end markets and is also a leading recycler in North America.
Read more on WM →
